You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Chronic Myeloid Leukemia Trial (Asciminib)

Available
  • Chronic Myeloid Leukemia
  • (no location specified)
Jan 17, 2023

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

Not yet recruiting
  • CML (Chronic Myelogenous Leukemia
  • (no location specified)
Jul 27, 2022

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

3L+ Therapies Among Chronic Myeloid Leukemia and Those With

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis Investigative Site
    Nov 11, 2022

    Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 27, 2022

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Treatment-free Remission
    • TFR(Treatment-Free Remission)
    • (no location specified)
    Jun 27, 2022

    Effect of Pharmacogenetics on Imatinib Plasma Level and Response

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • PCR
    • HPLC-UV
    • Assiut, Egypt
      South Egypt Cancer Institute
    Aug 6, 2022

    Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

    Completed
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Angers, France
    • +9 more
    Aug 17, 2022

    Chronic Myeloid Leukemia Trial in France (biological samples)

    Completed
    • Chronic Myeloid Leukemia
    • biological samples
    • Belfort, France
    • +3 more
    May 31, 2022

    Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Plasma Cell Myeloma Trial in Detroit (The DISCO

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • The DISCO App
    • Usual Care
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    May 31, 2022

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

    Recruiting
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Chronic Phase Chronic Myelogenous Leukemia
    • Text Message-Based Navigation Intervention
    • Survey Administration
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    New Diagnosed Chronic Phase Chronic Myeloid Leukemia

    Recruiting
    • Validity and Safety
      • Guangzhou, Guangdong, China
        NanfangH
      Apr 9, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +11 more
      • Duarte, California
        City of Hope Medical Center
      Dec 8, 2022

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023

      Among CP-CML Participants Initiating Dasatinib inReal Life

      Completed
      • Chronic Myeloid Leukemia
      • Non-Interventional
      • Paris, France
        Local Institution
      Jun 17, 2022

      Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

      Completed
      Has Results
      • Leukemia
      • +4 more
      • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Nov 10, 2022